{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:26:36Z","timestamp":1793305596692,"version":"4.5.0"},"reference-count":239,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2703902"],"award-info":[{"award-number":["2022YFC2703902"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2703901"],"award-info":[{"award-number":["2022YFC2703901"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241020"],"award-info":[{"award-number":["82241020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200065"],"award-info":[{"award-number":["82200065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.yjmcc.2024.10.004","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T10:07:17Z","timestamp":1729418837000},"page":"61-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"197","author":[{"given":"Ying-Huizi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Yu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Chen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Cheng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2024.10.004_bb0005","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary arterial hypertension","volume":"385","author":"Hassoun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0010","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrm3176","article-title":"Molecular control of endothelial cell behaviour during blood vessel morphogenesis","volume":"12","author":"Herbert","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0020","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.cell.2023.04.017","article-title":"Mechanisms of skin vascular maturation and maintenance captured by longitudinal imaging of live mice","volume":"186","author":"Kam","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0025","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.2147\/JIR.S418166","article-title":"Research progress and molecular mechanisms of endothelial cells inflammation in vascular-related diseases","volume":"16","author":"Xue","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jacasi.2022.09.010","article-title":"Pathogenic mechanisms of pulmonary arterial hypertension: homeostasis imbalance of endothelium-derived relaxing and contracting factors","volume":"2","author":"Zhu","year":"2022","journal-title":"JACC Asia"},{"issue":"79","key":"10.1016\/j.yjmcc.2024.10.004_bb0035","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/HYPERTENSIONAHA.122.18261","article-title":"Evolving concepts in endothelial pathobiology of pulmonary arterial hypertension","volume":"1979","author":"Cober","year":"2022","journal-title":"Hypertens. Dallas Tex"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01568","article-title":"Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41569-022-00770-1","article-title":"Vascular endothelial cell development and diversity","volume":"20","author":"Trimm","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0050","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1161\/ATVBAHA.114.303218","article-title":"Signaling pathways in the specification of arteries and veins","volume":"34","author":"Corada","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature03511","article-title":"Suppression of notch signalling by the COUP-TFII transcription factor regulates vein identity","volume":"435","author":"You","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1534-5807(02)00198-3","article-title":"sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation","volume":"3","author":"Lawson","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0065","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cell.2015.10.039","article-title":"Design and analysis of single-cell sequencing experiments","volume":"163","author":"Gr\u00fcn","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.120.052318","article-title":"Integrated single-cell atlas of endothelial cells of the human lung","volume":"144","author":"Schupp","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0075","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0085","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1038\/ncomms6758","article-title":"Arteries are formed by vein-derived endothelial tip cells","volume":"5","author":"Xu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800198","article-title":"Veins and arteries build hierarchical branching patterns differently: bottom-up versus top-down","volume":"41","author":"Red-Horse","year":"2019","journal-title":"BioEssays News Rev. Mol. Cell. Dev. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0095","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.121.054071","article-title":"Role of venous endothelial cells in developmental and pathologic angiogenesis","volume":"144","author":"Lee","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41422-022-00615-z","article-title":"Heterogeneity in endothelial cells and widespread venous arterialization during early vascular development in mammals","volume":"32","author":"Hou","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1097-0185(199703)247:3<413::AID-AR13>3.0.CO;2-S","article-title":"Expression of platelet-endothelial cell adhesion molecule-1 (PECAM) by macaque trophoblast cells during invasion of the spiral arteries","volume":"247","author":"Blankenship","year":"1997","journal-title":"Anat. Rec."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0110","article-title":"General capillary endothelial cells undergo reprogramming into arterial endothelial cells in pulmonary hypertension through HIF-2\u03b1\/Notch4 pathway","author":"Liu","year":"2024","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12967-024-05108-8","article-title":"Recent advances in endothelial colony-forming cells: from the transcriptomic perspective","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pharmthera.2013.10.002","article-title":"Targeted therapies in pulmonary arterial hypertension","volume":"141","author":"Montani","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/rcmb.2016-0418OC","article-title":"Targeting pulmonary endothelial hemoglobin \u03b1 improves nitric oxide signaling and reverses pulmonary artery endothelial dysfunction","volume":"57","author":"Alvarez","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0135","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0140","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201506-1231OC","article-title":"Delayed microvascular shear adaptation in pulmonary arterial hypertension. Role of platelet endothelial cell adhesion molecule-1 cleavage","volume":"193","author":"Szulcek","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chest.2021.08.040","article-title":"Phenotypic diversity of vascular smooth muscle cells in pulmonary arterial hypertension: implications for therapy","volume":"161","author":"Lechartier","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0150","article-title":"PDGF-A signaling is required for secondary alveolar septation and controls epithelial proliferation in the developing lung","volume":"145","author":"Gouveia","year":"2018","journal-title":"Dev. Camb. Engl."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0155","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF\u03b2 signalling in context","volume":"13","author":"Massagu\u00e9","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0160","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"issue":"64","key":"10.1016\/j.yjmcc.2024.10.004_bb0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.113.03037","article-title":"Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA\/programmed cell death 4\/caspase-3 axis","volume":"1979","author":"White","year":"2014","journal-title":"Hypertens. Dallas Tex"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0170","first-page":"L1046","article-title":"Suppression of endothelial CD39\/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"308","author":"Helenius","year":"2015","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0175","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200707-1083OC","article-title":"Role of the TGF-beta\/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension","volume":"177","author":"Zaiman","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/ATVBAHA.115.306710","article-title":"Hypoxia-inducible factor 1\u03b1 is a critical downstream mediator for hypoxia-induced mitogenic factor (FIZZ1\/RELM\u03b1)-induced pulmonary hypertension","volume":"36","author":"Johns","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1084\/jem.20111741","article-title":"Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension","volume":"211","author":"Sawada","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCRESAHA.118.313374","article-title":"Smooth muscle contact drives endothelial regeneration by BMPR2-Notch1-mediated metabolic and epigenetic changes","volume":"124","author":"Miyagawa","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0195","first-page":"L1250","article-title":"Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension","volume":"294","author":"Huang","year":"2008","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2022.104471","article-title":"PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension","volume":"146","author":"Liao","year":"2023","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0205","article-title":"AMPK and pulmonary hypertension: crossroads between vasoconstriction and vascular remodeling","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0210","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1172\/JCI118696","article-title":"Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats","volume":"97","author":"Voelkel","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0215","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3390\/ijms22042144","article-title":"mTOR signaling in pulmonary vascular disease: pathogenic role and therapeutic target","volume":"22","author":"Babicheva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0220","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1172\/JCI43382","article-title":"Disruption of PPAR\u03b3\/\u03b2-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival","volume":"121","author":"Alastalo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.lfs.2013.12.215","article-title":"Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin","volume":"118","author":"Van Hung","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0230","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0235","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3892\/ijmm.2015.2224","article-title":"Mammalian target of rapamycin overexpression antagonizes chronic hypoxia-triggered pulmonary arterial hypertension via the autophagic pathway","volume":"36","author":"Li","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0240","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/ATVBAHA.118.312038","article-title":"Injury-induced shedding of extracellular vesicles depletes endothelial cells of Cav-1 (Caveolin-1) and enables TGF-\u03b2 (transforming growth factor-\u03b2)-dependent pulmonary arterial hypertension","volume":"39","author":"Oliveira","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0245","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000369709","article-title":"Platelet-derived growth factor-B (PDGF-B) induced by hypoxia promotes the survival of pulmonary arterial endothelial cells through the PI3K\/Akt\/Stat3 pathway","volume":"35","author":"Li","year":"2015","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0250","first-page":"3058","article-title":"MicroRNA-126 affects cell apoptosis, proliferation, cell cycle and modulates VEGF\/TGF-\u03b2 levels in pulmonary artery endothelial cells","volume":"23","author":"Yuan","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2009.12.006","article-title":"Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials","volume":"126","author":"Jurasz","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0260","first-page":"L548","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1465-9921-10-95","article-title":"Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation","volume":"10","author":"Sakao","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0270","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-physiol-021115-105134","article-title":"The link between angiogenesis and endothelial metabolism","volume":"79","author":"Potente","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0280","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00522-2020","article-title":"Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension","volume":"56","author":"He","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0285","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-physiol-031620-123956","article-title":"Metabolism in pulmonary hypertension","volume":"83","author":"Xu","year":"2021","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0290","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCRESAHA.122.319967","article-title":"Understanding the pathobiology of pulmonary hypertension due to left heart disease","volume":"130","author":"Huston","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0300","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/stem.1280","article-title":"Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow","volume":"31","author":"Tura","year":"2013","journal-title":"Stem Cells Dayt. Ohio"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0305","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4103\/2045-8932.93547","article-title":"Pulmonary artery endothelium resident endothelial colony-forming cells in pulmonary arterial hypertension","volume":"1","author":"Duong","year":"2011","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0310","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12887-019-1884-x","article-title":"The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease","volume":"19","author":"Sun","year":"2019","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0315","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.healun.2012.06.005","article-title":"Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension","volume":"31","author":"Schiavon","year":"2012","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0320","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood-2012-03-419275","article-title":"Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension","volume":"120","author":"Asosingh","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0325","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/CIRCRESAHA.114.305951","article-title":"Endothelial NO-synthase gene-enhanced progenitor cell therapy for pulmonary arterial hypertension: the PHACeT trial","volume":"117","author":"Granton","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0330","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0335","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/CIRCGENETICS.111.962209","article-title":"BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension","volume":"5","author":"Liu","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0340","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.0000200180.01710.e6","article-title":"Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension","volume":"98","author":"Teichert-Kuliszewska","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0345","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.107.736801","article-title":"Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension","volume":"118","author":"Hong","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0350","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1465-9921-12-84","article-title":"Physiologic and molecular consequences of endothelial Bmpr2 mutation","volume":"12","author":"Majka","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0355","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01609-2018","article-title":"Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension","volume":"53","author":"Wang","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0360","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nm.3877","article-title":"Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0365","first-page":"427","article-title":"Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension","volume":"15","author":"Taraseviciene-Stewart","year":"2001","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/resp.12872","article-title":"Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: implications for pulmonary arterial hypertension","volume":"22","author":"Mumby","year":"2017","journal-title":"Respirol. Carlton Vic"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0375","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1183\/09031936.00044911","article-title":"A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease","volume":"39","author":"Costello","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0380","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fphys.2018.00138","article-title":"Vascular endothelial cell-specific connective tissue growth factor (CTGF) is necessary for development of chronic hypoxia-induced pulmonary hypertension","volume":"9","author":"Pi","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0385","doi-asserted-by":"crossref","first-page":"200ra117","DOI":"10.1126\/scitranslmed.3006674","article-title":"Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension","volume":"5","author":"Tian","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0390","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.201402-0322OC","article-title":"Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor\/CD74 complex","volume":"192","author":"Le Hiress","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0395","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101264","article-title":"Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension","volume":"5","author":"Florentin","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0400","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/cvr\/cvw070","article-title":"Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension","volume":"111","author":"Abe","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0405","article-title":"Endothelial heterogeneity in the response to autophagy drives small vessel muscularization in pulmonary hypertension","volume":"0","author":"Zhang","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0410","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00439-014-1419-3","article-title":"The genetic basis of pulmonary arterial hypertension","volume":"133","author":"Ma","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0415","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.122.19397","article-title":"The novel lysosomal autophagy inhibitor (ROC-325) ameliorates experimental pulmonary hypertension","volume":"80","author":"Bao","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0420","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201107-1293OC","article-title":"17\u03b2-estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects","volume":"185","author":"Lahm","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0425","series-title":"Ferroptosis Promotes Pulmonary Hypertension, bioRxiv","author":"Vogel","year":"2024"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0430","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0435","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0440","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175093","article-title":"The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11","volume":"928","author":"Hu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0450","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.3934\/mbe.2021377","article-title":"Identification of ferroptosis-associated genes exhibiting altered expression in pulmonary arterial hypertension","volume":"18","author":"Zhang","year":"2021","journal-title":"Math. Biosci. Eng. MBE"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0455","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.65","article-title":"Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis","volume":"6","author":"Fan","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0460","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1038\/s41598-022-06848-7","article-title":"Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation","volume":"12","author":"Xie","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0465","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbrc.2019.05.147","article-title":"miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis","volume":"515","author":"Xiao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0470","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.freeradbiomed.2012.08.576","article-title":"Iron chelation inhibits the development of pulmonary vascular remodeling","volume":"53","author":"Wong","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0475","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12265-023-10423-4","article-title":"Ferrostatin-1 blunts right ventricular hypertrophy and dysfunction in pulmonary arterial hypertension by suppressing the HMOX1\/GSH signaling","volume":"17","author":"Song","year":"2024","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0480","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41420-023-01535-6","article-title":"Molecular regulation and therapeutic implications of cell death in pulmonary hypertension","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0485","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ctm2.13","article-title":"NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases","volume":"10","author":"Wang","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0490","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12101","article-title":"Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation","volume":"12","author":"Mavrogiannis","year":"2022","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0495","first-page":"L472","article-title":"GLI1-mediated pulmonary artery smooth muscle cell pyroptosis contributes to hypoxia-induced pulmonary hypertension","volume":"318","author":"He","year":"2020","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0500","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCRESAHA.119.315229","article-title":"Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension","volume":"125","author":"Kurosawa","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0505","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0510","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1073\/pnas.1821401116","article-title":"PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension","volume":"116","author":"Cao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"80","key":"10.1016\/j.yjmcc.2024.10.004_bb0515","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/HYPERTENSIONAHA.122.19857","article-title":"Targeting endothelial ENO1 (alpha-enolase) -PI3K-Akt-mTOR axis alleviates hypoxic pulmonary hypertension","volume":"1979","author":"Shi","year":"2023","journal-title":"Hypertens. Dallas Tex"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0520","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCRESAHA.122.321200","article-title":"Endothelial FIS1 DeSUMOylation protects against hypoxic pulmonary hypertension","volume":"133","author":"Zhou","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0525","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2353\/ajpath.2010.090832","article-title":"Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells","volume":"176","author":"Fijalkowska","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0530","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.202203-0450OC","article-title":"SOX17 deficiency mediates pulmonary hypertension: at the crossroads of sex, metabolism, and genetics","volume":"207","author":"Sangam","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0535","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/2045893217701917","article-title":"Metabolic and functional evaluation of the heart and lungs in pulmonary hypertension by gated 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography","volume":"7","author":"Saygin","year":"2017","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0540","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/j.2040-4603.2020.tb00125.x","article-title":"Mitochondria in the pulmonary vasculature in health and disease: oxygen-sensing, metabolism, and dynamics","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0545","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/690236","article-title":"Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension","volume":"7","author":"Egnatchik","year":"2017","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0550","first-page":"L545","article-title":"Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats","volume":"307","author":"Chettimada","year":"2014","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0555","first-page":"L287","article-title":"Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension","volume":"308","author":"Chettimada","year":"2015","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0560","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1073\/pnas.170282597","article-title":"Molecular mechanism of endothelial growth arrest by laminar shear stress","volume":"97","author":"Lin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0565","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1007\/s00018-013-1382-5","article-title":"MicroRNAs in pulmonary arterial remodeling","volume":"70","author":"Grant","year":"2013","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0570","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.118.313447","article-title":"LncRNAs coming of age","volume":"123","author":"Grote","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0575","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-022-01582-0","article-title":"The functional roles of the circRNA\/Wnt axis in cancer","volume":"21","author":"Xue","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0580","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCRESAHA.107.153916","article-title":"Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis","volume":"101","author":"Kuehbacher","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0585","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11325-016-1351-y","article-title":"The emerging role of microRNAs in hypoxia-induced pulmonary hypertension","volume":"20","author":"Mohsenin","year":"2016","journal-title":"Sleep Breath. Schlaf Atm."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0590","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5483\/BMBRep.2014.47.6.085","article-title":"Therapeutic implications of microRNAs in pulmonary arterial hypertension","volume":"47","author":"Lee","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0595","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.109.197491","article-title":"Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17\/92 pathway","volume":"104","author":"Brock","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0600","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/ATVBAHA.109.202028","article-title":"Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline","volume":"30","author":"Caruso","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/BJ20140486","article-title":"miR-21\/DDAH1 pathway regulates pulmonary vascular responses to hypoxia","volume":"462","author":"Iannone","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0610","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20101812","article-title":"Role for miR-204 in human pulmonary arterial hypertension","volume":"208","author":"Courboulin","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079503","article-title":"Hypoxia mediates mutual repression between microRNA-27a and PPAR\u03b3 in the pulmonary vasculature","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0620","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbrc.2015.03.057","article-title":"MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor \u03b3 dependent Hsp90-eNOS signaling and nitric oxide production","volume":"460","author":"Bi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0625","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3892\/ijmm.2021.4949","article-title":"FGF21 attenuates hypoxia-induced dysfunction and inflammation in HPAECs via the microRNA-27b-mediated PPAR\u03b3 pathway","volume":"47","author":"Yao","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0630","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1002\/jcp.29318","article-title":"miR-181a\/b-5p ameliorates inflammatory response in monocrotaline-induced pulmonary arterial hypertension by targeting endocan","volume":"235","author":"Zhao","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0635","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.1038\/s41598-019-46352-z","article-title":"MicroRNA410 inhibits pulmonary vascular remodeling via regulation of nicotinamide phosphoribosyltransferase","volume":"9","author":"Gao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0640","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1177\/1535370215579018","article-title":"Featured article: microRNA-125a in pulmonary hypertension: regulator of a proliferative phenotype of endothelial cells","volume":"240","author":"Huber","year":"2015","journal-title":"Exp. Biol. Med. Maywood NJ"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0645","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm.3040","article-title":"An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension","volume":"19","author":"Kim","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0650","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/CIRCULATIONAHA.114.013339","article-title":"Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension","volume":"131","author":"Kim","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0655","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.febslet.2014.01.033","article-title":"Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunction","volume":"588","author":"Sen","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0660","first-page":"236","article-title":"MicroRNA-30a-5p promotes proliferation and inhibits apoptosis of human pulmonary artery endothelial cells under hypoxia by targeting YKL-40","volume":"20","author":"Tan","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0665","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.biopha.2018.04.172","article-title":"MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2\/Smad1 signaling","volume":"103","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0670","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/COPD.S99318","article-title":"Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells","volume":"12","author":"Li","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0675","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2015.01.009","article-title":"A micropeptide encoded by a putative long noncoding RNA regulates muscle performance","volume":"160","author":"Anderson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0680","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature21034","article-title":"mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide","volume":"541","author":"Matsumoto","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0685","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2029","article-title":"Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension","volume":"16","author":"Tai","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0690","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s10020-022-00551-z","article-title":"LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation","volume":"28","author":"Wang","year":"2022","journal-title":"Mol. Med. Camb. Mass"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0695","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ncrna9010010","article-title":"Computational methods to study DNA:DNA:RNA triplex formation by lncRNAs","volume":"9","author":"Warwick","year":"2023","journal-title":"Non-Coding RNA"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0700","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/ATVBAHA.122.318842","article-title":"Super enhancer-associated circular RNA-CircKrt4 regulates hypoxic pulmonary artery endothelial cell dysfunction in mice","volume":"43","author":"Ma","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"75","key":"10.1016\/j.yjmcc.2024.10.004_bb0705","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.119.13715","article-title":"Circ-calm4 serves as an miR-337-3p sponge to regulate Myo10 (myosin 10) and promote pulmonary artery smooth muscle proliferation","volume":"1979","author":"Zhang","year":"2020","journal-title":"Hypertens. Dallas Tex"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0710","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031867","article-title":"CircALMS1 alleviates pulmonary microvascular endothelial cell dysfunction in pulmonary hypertension","volume":"13","author":"Hu","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0715","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12931-022-02248-7","article-title":"CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p\/BMPR2 axis","volume":"23","author":"Sun","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0720","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ame2.12332","article-title":"CircPMS1 promotes proliferation of pulmonary artery smooth muscle cells, pulmonary microvascular endothelial cells, and pericytes under hypoxia","volume":"7","author":"Hu","year":"2024","journal-title":"Anim. Models Exp. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0725","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41467-018-03672-4","article-title":"Identification of rare sequence variation underlying heritable pulmonary arterial hypertension","volume":"9","author":"Gr\u00e4f","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0730","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa1211097","article-title":"A novel channelopathy in pulmonary arterial hypertension","volume":"369","author":"Ma","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0735","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jcbfm.2011.159","article-title":"Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8","volume":"32","author":"Woo","year":"2012","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0740","first-page":"C959","article-title":"Shear stress increases expression of a KATP channel in rat and bovine pulmonary vascular endothelial cells","volume":"285","author":"Chatterjee","year":"2003","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0745","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/cvr\/cvae068","article-title":"ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport","volume":"120","author":"Liu","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0750","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.115.020951","article-title":"Potassium Channel subfamily K member 3 (KCNK3) contributes to the development of pulmonary arterial hypertension","volume":"133","author":"Antigny","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0755","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/biom11060795","article-title":"Restoration of vitamin D levels improves endothelial function and increases TASK-like K+ currents in pulmonary arterial hypertension associated with vitamin D deficiency","volume":"11","author":"Callejo","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0760","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.3390\/ijms21176125","article-title":"TRPC and TRPV channels\u2019 role in vascular remodeling and disease","volume":"21","author":"Mart\u00edn-B\u00f3rnez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0765","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023130118","article-title":"Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension","volume":"118","author":"Daneva","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0770","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.freeradbiomed.2024.04.224","article-title":"TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis","volume":"219","author":"Yang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0775","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1165\/rcmb.2016-0344OC","article-title":"Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38-mitogen-activated protein kinase-dependent apoptosis","volume":"58","author":"Allawzi","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0780","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1165\/rcmb.2022-0111OC","article-title":"Intracellular chloride channels regulate endothelial metabolic reprogramming in pulmonary arterial hypertension","volume":"68","author":"Alzaydi","year":"2023","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0785","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019875417","article-title":"Iptakalim ameliorates hypoxia-impaired human endothelial colony-forming cells proliferation, migration, and angiogenesis via Akt\/eNOS pathways","volume":"9","author":"He","year":"2019","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0790","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1074\/jbc.M203161200","article-title":"Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0795","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202109144","article-title":"A mitochondrial contribution to anti-inflammatory shear stress signaling in vascular endothelial cells","volume":"221","author":"Coon","year":"2022","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0800","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1073\/pnas.1707517114","article-title":"Systems biology analysis of longitudinal functional response of endothelial cells to shear stress","volume":"114","author":"Ajami","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0805","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cvr\/cvz027","article-title":"Identification of atheroprone shear stress responsive regulatory elements in endothelial cells","volume":"115","author":"Bondareva","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0810","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.606989","article-title":"Cyclic stretch induces vascular smooth muscle cells to secrete connective tissue growth factor and promote endothelial progenitor cell differentiation and angiogenesis","volume":"8","author":"Yan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0815","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/2045-8932.105035","article-title":"Wall shear stress is decreased in the pulmonary arteries of patients with pulmonary arterial hypertension: an image-based, computational fluid dynamics study","volume":"2","author":"Tang","year":"2012","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0820","first-page":"C1010","article-title":"Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertension","volume":"321","author":"Wang","year":"2021","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0825","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2022.08.006","article-title":"Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension","volume":"218","author":"Chen","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0830","article-title":"Piezo1 channel activation reverses pulmonary artery vasoconstriction in an early rat model of pulmonary hypertension: the role of Ca2+ influx and Akt-eNOS pathway","volume":"11","author":"T","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0835","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141775","article-title":"Endothelial Piezo1 sustains muscle capillary density and contributes to physical activity","volume":"132","author":"Bartoli","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0840","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jbiomech.2017.12.022","article-title":"Image-based computational assessment of vascular wall mechanics and hemodynamics in pulmonary arterial hypertension patients","volume":"68","author":"Zambrano","year":"2018","journal-title":"J. Biomech."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0845","first-page":"L7","article-title":"Progress in solving the sex hormone paradox in pulmonary hypertension","volume":"307","author":"Lahm","year":"2014","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0850","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1378\/chest.10-3114","article-title":"Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management","volume":"141","author":"Shapiro","year":"2012","journal-title":"Chest"},{"issue":"72","key":"10.1016\/j.yjmcc.2024.10.004_bb0855","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.118.10963","article-title":"Impact of pituitary-gonadal axis hormones on pulmonary arterial hypertension in men","volume":"1979","author":"Wu","year":"2018","journal-title":"Hypertens. Dallas Tex"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0860","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mce.2016.11.019","article-title":"Unliganded estrogen receptor alpha regulates vascular cell function and gene expression","volume":"442","author":"Lu","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0865","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","article-title":"A transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114721","article-title":"G protein-coupled estrogen receptor regulates the KLF2-dependent eNOS expression by activating of Ca2+ and EGFR signaling pathway in human endothelial cells","volume":"192","author":"Park","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0875","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad079","article-title":"Estrogen and the vascular endothelium: the unanswered questions","volume":"164","author":"SenthilKumar","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0880","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/JOE-15-0257","article-title":"G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity","volume":"227","author":"Meyer","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0885","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/hq0901.095565","article-title":"Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women","volume":"21","author":"Saitta","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0890","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/cvr\/cvn360","article-title":"Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress","volume":"81","author":"Conway","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0895","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.RES.0000233318.85181.2e","article-title":"2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle","volume":"99","author":"Barchiesi","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0900","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.vph.2008.02.001","article-title":"2-Ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling","volume":"48","author":"Tofovic","year":"2008","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0905","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1476-5381.1993.tb13871.x","article-title":"Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats","volume":"110","author":"Farhat","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0910","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/679724","article-title":"The sexual dimorphism associated with pulmonary hypertension corresponds to a fibrotic phenotype","volume":"5","author":"Rafikova","year":"2015","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0915","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/rccm.201906-1217LE","article-title":"Exogenous estrogen preserves distal pulmonary arterial mechanics and prevents pulmonary hypertension in rats","volume":"201","author":"Philip","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0920","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019488","article-title":"Penetrance of severe pulmonary arterial hypertension in response to vascular endothelial growth factor receptor 2 blockade in a genetically prone rat model is reduced by female sex","volume":"10","author":"Chaudhary","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175558","article-title":"Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension","volume":"943","author":"Abdulkareem","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0930","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.201403-0483OC","article-title":"Sex-dependent influence of endogenous estrogen in pulmonary hypertension","volume":"190","author":"Mair","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0935","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1172\/JCI74773","article-title":"Systems-level regulation of microRNA networks by miR-130\/301 promotes pulmonary hypertension","volume":"124","author":"Bertero","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0940","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/rccm.201710-2079OC","article-title":"Therapeutic targeting of vascular remodeling and right heart failure in pulmonary arterial hypertension with a HIF-2\u03b1 inhibitor","volume":"198","author":"Dai","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0945","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00378-2019","article-title":"Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension","volume":"54","author":"Hu","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0950","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.123.067005","article-title":"ErbB3 governs endothelial dysfunction in hypoxia-induced pulmonary hypertension","author":"Bian","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0955","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/CIRCRESAHA.115.306806","article-title":"MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension","volume":"117","author":"Deng","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0960","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/antiox12010071","article-title":"Specificity protein 1-mediated promotion of CXCL12 advances endothelial cell metabolism and proliferation in pulmonary hypertension","volume":"12","author":"DeVallance","year":"2022","journal-title":"Antioxid. Basel Switz."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0965","doi-asserted-by":"crossref","first-page":"13641","DOI":"10.3390\/ijms232113641","article-title":"Non-muscle MLCK contributes to endothelial cell hyper-proliferation through the ERK pathway as a mechanism for vascular remodeling in pulmonary hypertension","volume":"23","author":"Anis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0970","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/thoraxjnl-2018-211846","article-title":"Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of \u03b2-catenin","volume":"74","author":"Wang","year":"2019","journal-title":"Thorax"},{"issue":"71","key":"10.1016\/j.yjmcc.2024.10.004_bb0975","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/HYPERTENSIONAHA.117.10350","article-title":"Growth differentiation factor 11 promotes abnormal proliferation and angiogenesis of pulmonary artery endothelial cells","volume":"1979","author":"Yu","year":"2018","journal-title":"Hypertens. Dallas Tex"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0980","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1378\/chest.129.3.696","article-title":"Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension","volume":"129","author":"Achcar","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0985","doi-asserted-by":"crossref","first-page":"76165","DOI":"10.18632\/oncotarget.19191","article-title":"Inhibitory effect of caveolin-1 in vascular endothelial cells, pericytes and smooth muscle cells","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0990","doi-asserted-by":"crossref","first-page":"H542","DOI":"10.1152\/ajpheart.00125.2021","article-title":"Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation","volume":"321","author":"Sahoo","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb0995","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1183\/13993003.00773-2015","article-title":"Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension","volume":"48","author":"Dabral","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1000","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehx700","volume":"39","author":"Bermejo","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1005","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"AMBITION investigators, initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"PATENT-1 Study Group, Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1015","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136459","article-title":"Frataxin deficiency promotes endothelial senescence in pulmonary hypertension","volume":"131","author":"Culley","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41569-022-00739-0","article-title":"Mechanisms and consequences of endothelial cell senescence","volume":"20","author":"Bloom","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/cvr\/cvab161","article-title":"Senescence mechanisms and targets in the heart","volume":"118","author":"Chen","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1030","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCRESAHA.121.319815","article-title":"Endothelial senescence: a new age in pulmonary hypertension","volume":"130","author":"Culley","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw4974","article-title":"Cellular senescence impairs the reversibility of pulmonary arterial hypertension","volume":"12","author":"van der Feen","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1040","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.122.058794","article-title":"Eliminating senescent cells can promote pulmonary hypertension development and progression","volume":"147","author":"Born","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1045","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.114.008750","article-title":"Endothelial-to-mesenchymal transition in pulmonary hypertension","volume":"131","author":"Ranchoux","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fimmu.2018.00294","article-title":"Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction","volume":"9","author":"Cho","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1183\/09031936.00187310","article-title":"Targeted gene delivery of BMPR2 attenuates pulmonary hypertension","volume":"39","author":"Reynolds","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1060","article-title":"BMPR1A promotes ID2-ZEB1 interaction to suppress excessive endothelial to mesenchymal transition","volume":"119","author":"Hw","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1065","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1002\/jcp.26195","article-title":"Bone morphogenetic protein-7 inhibits endothelial-mesenchymal transition in pulmonary artery endothelial cell under hypoxia","volume":"233","author":"Zhang","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1070","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/ars.2018.7673","article-title":"Focus on early events: pathogenesis of pulmonary arterial hypertension development","volume":"31","author":"Rafikova","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","article-title":"Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension","volume":"176","author":"Sanchez","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1080","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.healun.2022.12.012","article-title":"Vascular pathobiology of pulmonary hypertension","volume":"42","author":"Gallardo-Vara","year":"2023","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.201709-1835OC","article-title":"Endothelial and smooth muscle cell interaction via FoxM1 signaling mediates vascular remodeling and pulmonary hypertension","volume":"198","author":"Dai","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1090","first-page":"L256","article-title":"Endothelial HIF-2\u03b1 contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition","volume":"314","author":"Tang","year":"2018","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1095","first-page":"270","article-title":"Hypoxia induces endothelial-mesenchymal transition in pulmonary vascular remodeling","volume":"42","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1100","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/jcb.26376","article-title":"Anti-apoptosis endothelial cell-secreted microRNA-195-5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension","volume":"119","author":"Zeng","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1105","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03957-2020","article-title":"Endothelial cells in the pathogenesis of pulmonary arterial hypertension","volume":"58","author":"Evans","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yjmcc.2018.06.006","article-title":"MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia\/15-HETE in pulmonary endothelial cells","volume":"121","author":"Liu","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1115","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCULATIONAHA.113.007469","article-title":"Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension","volume":"129","author":"Ricard","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213890","article-title":"Endothelial cells are a source of nestin expression in pulmonary arterial hypertension","volume":"14","author":"Bhagwani","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1125","first-page":"1458","article-title":"Inhibition of CXCR4 ameliorates hypoxia-induced pulmonary arterial hypertension in rats","volume":"13","author":"Xu","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1130","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020908782","article-title":"Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension","volume":"10","author":"Saygin","year":"2020","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1165\/rcmb.2017-0129OC","article-title":"A potential role for exosomal translationally controlled tumor protein export in vascular remodeling in pulmonary arterial hypertension","volume":"59","author":"Ferrer","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1140","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1145","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"STELLAR trial investigators, phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1150","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1172\/JCI65592","article-title":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension","volume":"123","author":"Spiekerkoetter","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1155","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02449-2016","article-title":"Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension","volume":"50","author":"Spiekerkoetter","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1160","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCRESAHA.118.313356","article-title":"Selective BMP-9 inhibition partially protects against experimental pulmonary hypertension","volume":"124","author":"Tu","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1165","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/CIRCRESAHA.119.314753","article-title":"The Janus faces of bone morphogenetic protein 9 in pulmonary arterial hypertension","volume":"124","author":"Ormiston","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1170","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201001-0123OC","article-title":"Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy","volume":"182","author":"Ghofrani","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1175","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","article-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study","volume":"127","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1180","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.healun.2015.05.025","article-title":"Long-term safety and efficacy of imatinib in pulmonary arterial hypertension","volume":"34","author":"Frost","year":"2015","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1185","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201412-2291OC","article-title":"Elafin reverses pulmonary hypertension via caveolin-1-dependent bone morphogenetic protein signaling","volume":"191","author":"Nickel","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2024.10.004_bb1190","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCRESAHA.122.321532","article-title":"MED1 regulates BMP\/TGF-\u03b2 in endothelium: implication for pulmonary hypertension","volume":"131","author":"Wang","year":"2022","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2024.10.004_bib1191","first-page":"61","article-title":"BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition","volume":"10","author":"Meng","year":"2023","journal-title":"Mil. Med. Res."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282824001652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282824001652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:06:43Z","timestamp":1778641603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282824001652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":239,"alternative-id":["S0022282824001652"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2024.10.004","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2024.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}